https://sputnikglobe.com/20210729/argentina-receives-500-litres-of-active-substance-for-sputnik-vs-2nd-component-1083482774.html
Argentina Receives 500 Litres of Active Substance for Sputnik V's 2nd Component
Argentina Receives 500 Litres of Active Substance for Sputnik V's 2nd Component
Sputnik International
BUENOS AIRES (Sputnik) - Argentina has received 500 litres (132 gallons) of the active substance to produce the second component of the Russian COVID-19... 29.07.2021, Sputnik International
2021-07-29T07:27+0000
2021-07-29T07:27+0000
2021-07-29T09:10+0000
latin america
world
newsfeed
russia
russia
argentina
sputnik v vaccine
covid-19
coronavirus
vaccine
https://cdn1.img.sputnikglobe.com/img/07e5/07/08/1083333351_0:160:3073:1888_1920x0_80_0_0_8f137779176dc6019a7992a000bebaff.jpg
"Today, another 500 litres [of the active substance] of the Sputnik V second component arrived in our country, which will allow us to continue producing approximately 760,000 doses. Soon they will be available to our people", the laboratory said.Earlier this month, the Richmond Laboratory announced that it had completed the production of the first 153,441 doses of the second component of the Sputnik V vaccine, stating plans to produce more.In March of this year, Argentina's authorities started to immunise citizens with only the first shot of Sputnik V, while the second phase of vaccination was postponed for three months.On 7 July, the Argentine government sent a letter to the Russian Direct Investment Fund, responsible for marketing Sputnik V overseas. The letter said that the Latin American country urgently needed the second component of the vaccine, which is different from the first dose, and warned that a supply agreement was at risk.Argentina was the first Latin American country both to authorise the use of the Sputnik V vaccine and to localise production. In April, it announced plans to produce 4-5 million doses of Russia's vaccine monthly and expects to ramp up yearly production to 500 million doses.Currently, vaccines approved for use in Argentina include Sputnik V, Pfizer/BioNTech, Oxford/AstraZeneca, Covishield, and China's Convidecia and Sinopharm.
russia
argentina
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
2021
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
News
en_EN
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
latin america, newsfeed, russia, argentina, sputnik v vaccine, covid-19, coronavirus, vaccine
latin america, newsfeed, russia, argentina, sputnik v vaccine, covid-19, coronavirus, vaccine
Argentina Receives 500 Litres of Active Substance for Sputnik V's 2nd Component
07:27 GMT 29.07.2021 (Updated: 09:10 GMT 29.07.2021) BUENOS AIRES (Sputnik) - Argentina has received 500 litres (132 gallons) of the active substance to produce the second component of the Russian COVID-19 vaccine Sputnik V, Argentina's Richmond Laboratory said on Twitter.
"Today, another 500 litres [of the active substance] of the Sputnik V second component arrived in our country, which will allow us to continue producing approximately 760,000 doses. Soon they will be available to our people", the laboratory said.
Earlier this month, the Richmond Laboratory announced that
it had completed the production of the first 153,441 doses of the second component of the Sputnik V vaccine, stating plans to produce more.
In March of this year, Argentina's authorities started to immunise citizens with only the first shot of Sputnik V, while the second phase of vaccination was postponed for three months.
On 7 July, the Argentine government sent a letter to the Russian Direct Investment Fund, responsible for marketing Sputnik V overseas. The letter said that the Latin American country urgently needed the second component of the vaccine, which is different from the first dose, and warned that a supply agreement was at risk.
Argentina was the first Latin American country both to authorise the
use of the Sputnik V vaccine and to localise production. In April, it announced plans to produce 4-5 million doses of Russia's vaccine monthly and expects to ramp up yearly production to 500 million doses.
Currently, vaccines approved for use in Argentina include Sputnik V, Pfizer/BioNTech, Oxford/AstraZeneca, Covishield, and China's Convidecia and Sinopharm.
